Published in Hum Mol Genet on September 21, 2012
Ribosomal frameshifting in the CCR5 mRNA is regulated by miRNAs and the NMD pathway. Nature (2014) 1.20
Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. Cerebellum (2014) 1.03
Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease. Adv Exp Med Biol (2014) 0.92
Genetic landscape remodelling in spinocerebellar ataxias: the influence of next-generation sequencing. J Neurol (2015) 0.83
Mechanism and Regulation of Protein Synthesis in Saccharomyces cerevisiae. Genetics (2016) 0.82
Cell cycle control (and more) by programmed -1 ribosomal frameshifting: implications for disease and therapeutics. Cell Cycle (2015) 0.80
Identification and characterization of novel PDYN mutations in dominant cerebellar ataxia cases. J Neurol (2013) 0.80
Ribosomes in the balance: structural equilibrium ensures translational fidelity and proper gene expression. Nucleic Acids Res (2014) 0.79
Cerebellar ataxias: β-III spectrin's interactions suggest common pathogenic pathways. J Physiol (2016) 0.79
Novel de novo EEF1A2 missense mutations causing epilepsy and intellectual disability. Mol Genet Genomic Med (2016) 0.78
Reprogramming the genetic code: The emerging role of ribosomal frameshifting in regulating cellular gene expression. Bioessays (2015) 0.78
Polyglutamine spinocerebellar ataxias - from genes to potential treatments. Nat Rev Neurosci (2017) 0.75
The Sequence Alignment/Map format and SAMtools. Bioinformatics (2009) 232.39
A map of human genome variation from population-scale sequencing. Nature (2010) 121.13
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res (2010) 97.51
Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics (2010) 52.01
Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc (2009) 38.62
Targeted capture and massively parallel sequencing of 12 human exomes. Nature (2009) 33.96
Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol (2007) 33.06
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature (2006) 24.39
Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature (2006) 21.40
Distribution and intensity of constraint in mammalian genomic sequence. Genome Res (2005) 18.85
Adapting proteostasis for disease intervention. Science (2008) 13.22
A novel mechanism for regulating activity of a transcription factor that controls the unfolded protein response. Cell (1996) 8.17
Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science (2006) 5.39
Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature (2006) 5.07
TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing. Brain (2010) 3.66
Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell (1995) 3.64
Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proc Natl Acad Sci U S A (2009) 3.44
Reprogrammed genetic decoding in cellular gene expression. Mol Cell (2004) 3.11
Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet (2001) 3.05
Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet (2010) 2.66
Visualization of elongation factor G on the Escherichia coli 70S ribosome: the mechanism of translocation. Proc Natl Acad Sci U S A (1998) 2.53
Structures of modified eEF2 80S ribosome complexes reveal the role of GTP hydrolysis in translocation. EMBO J (2007) 2.48
An in vivo dual-luciferase assay system for studying translational recoding in the yeast Saccharomyces cerevisiae. RNA (2003) 2.42
Large-scale movement of elongation factor G and extensive conformational change of the ribosome during translocation. Cell (2000) 2.35
Spectrin mutations cause spinocerebellar ataxia type 5. Nat Genet (2006) 2.34
Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement. Am J Hum Genet (2011) 2.19
The 9-A solution: how mRNA pseudoknots promote efficient programmed -1 ribosomal frameshifting. RNA (2003) 2.14
Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Nat Genet (2006) 2.09
The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum (2005) 2.08
A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. Am J Hum Genet (2002) 2.02
Protein accumulation and neurodegeneration in the woozy mutant mouse is caused by disruption of SIL1, a cochaperone of BiP. Nat Genet (2005) 1.98
Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n. Am J Hum Genet (2009) 1.96
Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J Biol Chem (2008) 1.92
Spinocerebellar ataxia 2 (SCA2). Cerebellum (2008) 1.84
Moonlighting functions of polypeptide elongation factor 1: from actin bundling to zinc finger protein R1-associated nuclear localization. Biosci Biotechnol Biochem (2002) 1.73
Two crystal structures demonstrate large conformational changes in the eukaryotic ribosomal translocase. Nat Struct Biol (2003) 1.69
Towards a genetic dissection of the basis of triplet decoding, and its natural subversion: programmed reading frame shifts and hops. Annu Rev Genet (1991) 1.62
Translation elongation factor 2 anticodon mimicry domain mutants affect fidelity and diphtheria toxin resistance. J Biol Chem (2006) 1.59
Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet (2009) 1.56
Chaperone networks: tipping the balance in protein folding diseases. Neurobiol Dis (2010) 1.42
Identification of functional, endogenous programmed -1 ribosomal frameshift signals in the genome of Saccharomyces cerevisiae. Nucleic Acids Res (2006) 1.40
Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11. Nat Genet (2007) 1.38
Akt phosphorylates acinus and inhibits its proteolytic cleavage, preventing chromatin condensation. EMBO J (2005) 1.35
The unfolded protein response in familial amyotrophic lateral sclerosis. Hum Mol Genet (2010) 1.33
SCA3: neurological features, pathogenesis and animal models. Cerebellum (2008) 1.31
The spinocerebellar ataxias. J Neuroophthalmol (2009) 1.30
Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23. Am J Hum Genet (2010) 1.27
Diphtheria toxin. Site and configuration of ADP-ribosylation of diphthamide in elongation factor 2. J Biol Chem (1981) 1.27
Cell biology of spinocerebellar ataxia. J Cell Biol (2012) 1.19
A programmed -1 ribosomal frameshift signal can function as a cis-acting mRNA destabilizing element. Nucleic Acids Res (2004) 1.18
Emerging pathogenic pathways in the spinocerebellar ataxias. Curr Opin Genet Dev (2009) 1.17
KCNC3: phenotype, mutations, channel biophysics-a study of 260 familial ataxia patients. Hum Mutat (2010) 1.17
Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias. Cerebellum (2010) 1.16
TATA-binding protein in neurodegenerative disease. Neuroscience (2005) 1.16
Alteration of the unfolded protein response modifies neurodegeneration in a mouse model of Marinesco-Sjögren syndrome. Hum Mol Genet (2010) 1.13
Molecular epidemiology of spinocerebellar ataxia type 6. Ann Neurol (2004) 1.12
Identification and characterisation of a developmentally regulated mammalian gene that utilises -1 programmed ribosomal frameshifting. Nucleic Acids Res (2001) 1.12
Elongation factor 2 mutants deficient in diphthamide formation show temperature-sensitive cell growth. J Biol Chem (1994) 1.12
Saccharomyces cerevisiae elongation factor 2. Genetic cloning, characterization of expression, and G-domain modeling. J Biol Chem (1992) 1.09
Mutations in the elongation factor 2 gene which confer resistance to diphtheria toxin and Pseudomonas exotoxin A. Genetic and biochemical analyses. J Biol Chem (1995) 1.05
Purification and crystallization of the yeast elongation factor eEF2. Acta Crystallogr D Biol Crystallogr (2002) 1.00
Dominant-negative mutant phenotypes and the regulation of translation elongation factor 2 levels in yeast. Nucleic Acids Res (2005) 0.99
The spinocerebellar ataxias: clinical aspects and molecular genetics. Adv Exp Med Biol (2012) 0.98
SCA15 due to large ITPR1 deletions in a cohort of 333 white families with dominant ataxia. Arch Neurol (2011) 0.97
Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol (2004) 0.96
SCA12: an unusual mutation leads to an unusual spinocerebellar ataxia. Brain Res Bull (2001) 0.94
Programmed Ribosomal Frameshifting Goes Beyond Viruses: Organisms from all three kingdoms use frameshifting to regulate gene expression, perhaps signaling a paradigm shift. Microbe Wash DC (2006) 0.92
Aggregate formation of mutant protein kinase C gamma found in spinocerebellar ataxia type 14 impairs ubiquitin-proteasome system and induces endoplasmic reticulum stress. Eur J Neurosci (2007) 0.92
Recent progress in spinocerebellar ataxia type-10 (SCA10). Cerebellum (2005) 0.91
Translation factors: in sickness and in health. Trends Biochem Sci (2004) 0.91
Protein kinase C gamma mutations in spinocerebellar ataxia 14 increase kinase activity and alter membrane targeting. Brain (2004) 0.90
Molecular pathogenesis of spinocerebellar ataxia type 6. Neurotherapeutics (2007) 0.90
Spectrin mutations in spinocerebellar ataxia (SCA). Bioessays (2006) 0.90
Saccharomyces cerevisiae elongation factor 2. Mutagenesis of the histidine precursor of diphthamide yields a functional protein that is resistant to diphtheria toxin. J Biol Chem (1993) 0.89
Diphthamide in elongation factor 2: ADP-ribosylation, purification, and properties. Methods Enzymol (1984) 0.89
A reproducible assay of polymerase chain reaction to detect trinucleotide repeat expansion of Huntington's disease and senile chorea. Neurol Res (1996) 0.88
Novel PRKCG/SCA14 mutation in a Dutch spinocerebellar ataxia family: expanding the phenotype. Mov Disord (2006) 0.87
A novel H101Q mutation causes PKCgamma loss in spinocerebellar ataxia type 14. J Hum Genet (2005) 0.87
Identification of a new family of spinocerebellar ataxia type 14 in the Japanese spinocerebellar ataxia population by the screening of PRKCG exon 4. Mov Disord (2006) 0.86
Spinocerebellar ataxia 7 (SCA7). Cytogenet Genome Res (2003) 0.86
SCA10 and ATTCT repeat expansion: clinical features and molecular aspects. Cytogenet Genome Res (2003) 0.85
Molecular pathogenesis of spinocerebellar ataxia type 1 disease. Mol Cells (2009) 0.85
Mutation of the highly conserved cysteine residue 131 of the SCA14 associated PRKCG gene in a family with slow progressive cerebellar ataxia. J Neurol (2006) 0.84
New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14. Ann Neurol (2005) 0.84
Genetics of the dominant ataxias. Semin Neurol (2012) 0.83
Molecular genetics of spinocerebellar ataxia type 8 (SCA8). RNA Biol (2005) 0.82
Expansion of the phenotypic spectrum of SCA14 caused by the Gly128Asp mutation in PRKCG. Clin Neurol Neurosurg (2008) 0.81
Spinocerebellar ataxia type 26 maps to chromosome 19p13.3 adjacent to SCA6. Ann Neurol (2005) 0.80
Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population. Hum Genet (2005) 0.80
Benign SCA14 phenotype in a German patient associated with a missense mutation in exon 3 of the PRKCG gene. Mov Disord (2007) 0.79
Codon 101 of PRKCG, a preferential mutation site in SCA14. Mov Disord (2007) 0.76
Spinocerebellar ataxia with mental retardation (SCA13). Cerebellum (2005) 0.76
Identification of functional elements and regulatory circuits by Drosophila modENCODE. Science (2010) 12.39
Unlocking the secrets of the genome. Nature (2009) 11.80
Gene expression during the life cycle of Drosophila melanogaster. Science (2002) 11.36
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res (2012) 9.13
Comparative genome sequencing of Drosophila pseudoobscura: chromosomal, gene, and cis-element evolution. Genome Res (2005) 8.38
Evolution of gene expression in the Drosophila melanogaster subgroup. Nat Genet (2003) 6.60
BAC TransgeneOmics: a high-throughput method for exploration of protein function in mammals. Nat Methods (2008) 6.51
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
A gene expression map for the euchromatic genome of Drosophila melanogaster. Science (2004) 5.38
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol (2008) 5.33
A cis-regulatory map of the Drosophila genome. Nature (2011) 4.80
Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance. Cell (2010) 4.37
Expression profiling in primates reveals a rapid evolution of human transcription factors. Nature (2006) 4.26
Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet (2006) 3.87
Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A (2011) 3.80
Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci U S A (2010) 3.58
Identification of genes involved in Drosophila melanogaster geotaxis, a complex behavioral trait. Nat Genet (2002) 3.53
Chromosomal distribution of PcG proteins during Drosophila development. PLoS Biol (2006) 3.41
Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A (2014) 3.35
Versatile P[acman] BAC libraries for transgenesis studies in Drosophila melanogaster. Nat Methods (2009) 3.35
A comprehensive map of insulator elements for the Drosophila genome. PLoS Genet (2010) 3.25
Multi-species microarrays reveal the effect of sequence divergence on gene expression profiles. Genome Res (2005) 3.23
Hotspots of transcription factor colocalization in the genome of Drosophila melanogaster. Proc Natl Acad Sci U S A (2006) 3.06
GeneTests-GeneClinics: genetic testing information for a growing audience. Hum Mutat (2002) 2.97
Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases. Mol Cell (2009) 2.84
Immune signaling pathways regulating bacterial and malaria parasite infection of the mosquito Anopheles gambiae. Proc Natl Acad Sci U S A (2005) 2.81
RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice. Cell (2006) 2.80
Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell (2009) 2.76
Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet (2004) 2.75
Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue. PLoS Genet (2011) 2.68
Tissue-specific gene expression and ecdysone-regulated genomic networks in Drosophila. Dev Cell (2003) 2.63
Genome expression analysis of Anopheles gambiae: responses to injury, bacterial challenge, and malaria infection. Proc Natl Acad Sci U S A (2002) 2.59
CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia. Blood (2012) 2.51
A statin-dependent QTL for GATM expression is associated with statin-induced myopathy. Nature (2013) 2.46
Duplicate genes increase gene expression diversity within and between species. Nat Genet (2004) 2.40
Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron (2003) 2.39
Spectrin mutations cause spinocerebellar ataxia type 5. Nat Genet (2006) 2.34
Systematic evaluation of factors influencing ChIP-seq fidelity. Nat Methods (2012) 2.31
Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. J Neurosci (2004) 2.29
Adaptive evolution and the birth of CTCF binding sites in the Drosophila genome. PLoS Biol (2012) 2.29
A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk. Cell (2013) 2.28
Hereditary cerebellar ataxia progressively impairs force adaptation during goal-directed arm movements. J Neurophysiol (2003) 2.26
Parallel on-chip gene synthesis and application to optimization of protein expression. Nat Biotechnol (2011) 2.22
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol (2010) 2.19
Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes. Nat Genet (2006) 2.09
A mutation accumulation assay reveals a broad capacity for rapid evolution of gene expression. Nature (2005) 2.08
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE. PLoS Genet (2011) 2.02
Control of mitochondrial structure and function by the Yorkie/YAP oncogenic pathway. Genes Dev (2012) 1.97
Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance. J Neurol Sci (2012) 1.97
Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders. Arch Neurol (2008) 1.89
Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol (2008) 1.89
Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. Am J Hum Genet (2002) 1.88
Shared predispositions of parkinsonism and cancer: a population-based pedigree-linked study. Arch Neurol (2012) 1.87
RNA-seq differential expression studies: more sequence or more replication? Bioinformatics (2013) 1.87
Analysis of Drosophila segmentation network identifies a JNK pathway factor overexpressed in kidney cancer. Science (2009) 1.83
Hereditary spastic paraplegias: an update. Curr Opin Neurol (2007) 1.83
FXN methylation predicts expression and clinical outcome in Friedreich ataxia. Ann Neurol (2012) 1.83
Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia. Ann Neurol (2005) 1.83
Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders. Arch Neurol (2004) 1.82
ChIP-chip versus ChIP-seq: lessons for experimental design and data analysis. BMC Genomics (2011) 1.80
APOE and other loci affect age-at-onset in Alzheimer's disease families with PS2 mutation. Am J Med Genet B Neuropsychiatr Genet (2005) 1.80
Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal-recessive spastic paraplegia, including Kjellin syndrome. Am J Hum Genet (2008) 1.79
Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindreds. Arch Neurol (2005) 1.78
Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron (2012) 1.78
A genome-scale DNA repair RNAi screen identifies SPG48 as a novel gene associated with hereditary spastic paraplegia. PLoS Biol (2010) 1.77
Mutations in KCND3 cause spinocerebellar ataxia type 22. Ann Neurol (2012) 1.76
Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol (2004) 1.72
Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia. Am J Hum Genet (2012) 1.71
Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am J Hum Genet (2010) 1.70
Qualifying the relationship between sequence conservation and molecular function. Genome Res (2008) 1.69
Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol (2010) 1.68
Microparadigms: chains of collective reasoning in publications about molecular interactions. Proc Natl Acad Sci U S A (2006) 1.68
Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet (2005) 1.68
The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum Mol Genet (2003) 1.66
Antigliadin antibodies in Huntington's disease. Neurology (2004) 1.64
Evidence of abundant stop codon readthrough in Drosophila and other metazoa. Genome Res (2011) 1.60
Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J Neurosci (2009) 1.59
Hereditary ataxias: overview. Genet Med (2013) 1.58
Complicated forms of autosomal dominant hereditary spastic paraplegia are frequent in SPG10. Hum Mutat (2009) 1.57
Heterozygous OPA1 mutations in Behr syndrome. Brain (2010) 1.57
Identification of tightly regulated groups of genes during Drosophila melanogaster embryogenesis. Mol Syst Biol (2007) 1.53
Upregulated function of mitochondria-associated ER membranes in Alzheimer disease. EMBO J (2012) 1.53
KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations. Eur J Hum Genet (2012) 1.52
Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2. Am J Hum Genet (2004) 1.51
PNPLA6 mutations cause Boucher-Neuhauser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. Brain (2013) 1.51
Double trouble in hereditary neuropathy: concomitant mutations in the PMP-22 gene and another gene produce novel phenotypes. Arch Neurol (2006) 1.49
Clinical feature profile of spinocerebellar ataxia type 1-8 predicts genetically defined subtypes. Mov Disord (2005) 1.49
Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry. Anal Chim Acta (2008) 1.47
Noncoding regulatory sequences of Ciona exhibit strong correspondence between evolutionary constraint and functional importance. Genome Res (2004) 1.47
Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymia. Ann Neurol (2014) 1.47